Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 14 | 2010 | 268 | 1.750 |
Why?
|
| Chondrocytes | 5 | 2010 | 99 | 0.840 |
Why?
|
| Ankle Joint | 4 | 2003 | 39 | 0.660 |
Why?
|
| Knee Joint | 4 | 2010 | 572 | 0.580 |
Why?
|
| Extracellular Matrix | 4 | 2010 | 49 | 0.380 |
Why?
|
| Talus | 2 | 2010 | 13 | 0.370 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2002 | 40 | 0.370 |
Why?
|
| Cartilage | 3 | 1999 | 70 | 0.350 |
Why?
|
| Subtalar Joint | 1 | 2010 | 2 | 0.320 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 4 | 0.320 |
Why?
|
| Collagenases | 4 | 2002 | 14 | 0.320 |
Why?
|
| RNA, Messenger | 6 | 2002 | 283 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 138 | 0.300 |
Why?
|
| Proteoglycans | 3 | 2008 | 120 | 0.250 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 299 | 0.240 |
Why?
|
| Matrix Metalloproteinases | 2 | 2008 | 18 | 0.230 |
Why?
|
| Doxycycline | 2 | 1994 | 16 | 0.220 |
Why?
|
| Metalloendopeptidases | 5 | 1999 | 10 | 0.220 |
Why?
|
| Osteoarthritis | 5 | 2003 | 287 | 0.210 |
Why?
|
| In Situ Hybridization | 6 | 2002 | 49 | 0.210 |
Why?
|
| Collagen Type II | 1 | 2002 | 19 | 0.190 |
Why?
|
| Homeostasis | 1 | 2002 | 65 | 0.190 |
Why?
|
| Adult | 9 | 2010 | 6931 | 0.160 |
Why?
|
| Annexin A5 | 1 | 1999 | 1 | 0.150 |
Why?
|
| Immunohistochemistry | 4 | 2002 | 337 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 69 | 0.150 |
Why?
|
| Humans | 14 | 2010 | 22932 | 0.140 |
Why?
|
| Interleukin-1 | 2 | 1997 | 46 | 0.130 |
Why?
|
| Neutrophils | 1 | 1996 | 89 | 0.120 |
Why?
|
| Aging | 1 | 2002 | 1102 | 0.120 |
Why?
|
| Up-Regulation | 1 | 1996 | 144 | 0.110 |
Why?
|
| Matrix Metalloproteinase 8 | 3 | 2001 | 3 | 0.110 |
Why?
|
| Middle Aged | 8 | 2008 | 7915 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2001 | 462 | 0.090 |
Why?
|
| Lectins, C-Type | 2 | 2002 | 29 | 0.090 |
Why?
|
| Aggrecans | 2 | 2002 | 52 | 0.090 |
Why?
|
| Adolescent | 4 | 2002 | 1882 | 0.090 |
Why?
|
| Aged | 6 | 2003 | 7449 | 0.080 |
Why?
|
| Male | 8 | 2008 | 12460 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2001 | 132 | 0.080 |
Why?
|
| Cell Division | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cell Count | 1 | 2010 | 72 | 0.080 |
Why?
|
| Glycosaminoglycans | 2 | 2002 | 18 | 0.080 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2001 | 3 | 0.080 |
Why?
|
| Collagen | 2 | 2002 | 81 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2003 | 3729 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2001 | 537 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2008 | 4 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 36 | 0.070 |
Why?
|
| Body Patterning | 1 | 2008 | 3 | 0.070 |
Why?
|
| Culture Techniques | 2 | 1999 | 19 | 0.070 |
Why?
|
| Hemarthrosis | 1 | 2008 | 22 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 302 | 0.070 |
Why?
|
| Base Sequence | 2 | 1999 | 99 | 0.070 |
Why?
|
| Hemophilia A | 1 | 2008 | 48 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 82 | 0.070 |
Why?
|
| Joints | 1 | 2008 | 67 | 0.070 |
Why?
|
| Animals | 4 | 2008 | 3270 | 0.070 |
Why?
|
| Female | 6 | 2003 | 12958 | 0.060 |
Why?
|
| Penile Induration | 1 | 2008 | 115 | 0.060 |
Why?
|
| Chick Embryo | 2 | 1994 | 15 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 1994 | 18 | 0.060 |
Why?
|
| Tibia | 2 | 1994 | 197 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2003 | 65 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2002 | 54 | 0.050 |
Why?
|
| Immunoassay | 1 | 2002 | 33 | 0.050 |
Why?
|
| Procollagen | 1 | 2001 | 4 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 4 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1997 | 19 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1999 | 20 | 0.040 |
Why?
|
| Chickens | 1 | 1999 | 33 | 0.040 |
Why?
|
| Fetus | 1 | 1999 | 33 | 0.040 |
Why?
|
| Podiatry | 1 | 1997 | 1 | 0.030 |
Why?
|
| Metatarsophalangeal Joint | 1 | 1997 | 5 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1997 | 21 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1996 | 21 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 142 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 176 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1994 | 2 | 0.030 |
Why?
|
| Gelatinases | 1 | 1994 | 4 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 6 | 0.030 |
Why?
|
| Cell Death | 1 | 1994 | 34 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1994 | 124 | 0.030 |
Why?
|
| Child, Preschool | 1 | 1996 | 567 | 0.030 |
Why?
|
| Child | 1 | 1996 | 1157 | 0.020 |
Why?
|
| Time Factors | 1 | 1994 | 1261 | 0.020 |
Why?
|
| Synovitis | 1 | 2008 | 20 | 0.020 |
Why?
|
| Factor VIII | 1 | 2008 | 32 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 161 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2008 | 74 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 276 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 526 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 1238 | 0.010 |
Why?
|
| Bone Density | 1 | 2002 | 146 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 577 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1997 | 28 | 0.010 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 1997 | 3 | 0.010 |
Why?
|
| RNA | 1 | 1997 | 28 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 125 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1997 | 38 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 112 | 0.010 |
Why?
|
| Cadaver | 1 | 1997 | 284 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1997 | 118 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 638 | 0.010 |
Why?
|
| United States | 1 | 1997 | 1765 | 0.010 |
Why?
|